Table 1.
Characteristics of 116,539 patients hospitalized with COVID-19 by sex, Poland, March–December 2020.
| Variable | Total Sample | p | Women | p | Men | p | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall n (%) |
Fatal n (%) |
Non-Fatal n (%) |
Overall n (%) |
Fatal n (%) |
Non-Fatal n (%) |
Overall n (%) |
Fatal n (%) |
Non-Fatal n (%) |
||||
| n (%) | 116,539 (100%) | 21,490 (18.4%) | 95,049 (81.6%) | 55,624 (47.7%) |
8719 (15.7%) | 46,905 (84.3%) |
60,915 (52.3%) |
12,771 (21.0%) | 48,144 (79.0%) |
|||
| Age (years) | ||||||||||||
| 0–9 | 3725 (3.2%) |
2 (0.0%) |
3723 (3.9%) |
<0.0001 | 1609 (2.9%) |
0 (0.0%) |
1609 (3.4%) |
<0.0001 | 2116 (3.5%) |
2 (0.0%) |
2114 (4.4%) |
<0.0001 |
| 10–19 | 2154 (1.8%) |
6 (0.0%) |
2148 (2.3%) |
1062 (1.9%) |
0 (0.0%) |
1062 (2.3%) |
1092 (1.8%) |
6 (0.0%) |
1086 (2.3%) |
|||
| 20–29 | 5710 (4.9%) |
39 (0.2%) |
5671 (6.0%) |
3262 (5.9%) |
20 (0.2%) |
3242 (6.9%) |
2448 (4.0%) |
19 (0.1%) |
2429 (5.0%) |
|||
| 30–39 | 8794 (7.5%) |
152 (0.7%) |
8642 (9.1%) |
4463 (8.0%) |
53 (0.6%) |
4410 (9.4%) |
4331 (7.1%) |
99 (0.8%) |
4232 (8.8%) |
|||
| 40–49 | 11,147 (9.6%) |
445 (2.1%) |
10,702 (11.3%) |
5244 (9.4%) |
121 (1.4%) |
5123 (10.9%) |
5903 (9.7%) |
324 (2.5%) |
5579 (11.6%) |
|||
| 50–59 | 15,248 (13.1%) |
1364 (6.3%) |
13,884 (14.6%) |
7176 (12.9%) |
402 (4.6%) |
6774 (14.4%) |
8072 (13.3%) |
962 (7.5%) |
7110 (14.8%) |
|||
| 60–69 | 24,358 (20.9%) |
4401 (20.5%) |
19,957 (21.0%) |
9859 (17.7%) |
1333 (15.3%) |
8526 (18.2%) |
14,499 (23.8%) |
3068 (24.0%) |
11,431 (23.7%) |
|||
| 70–79 | 23,678 (20.3%) |
6490 (30.2%) |
17,188 (18.1%) |
10,749 (19.3%) |
2506 (28.7%) |
8243 (17.6%) |
12,929 (21.2%) |
3984 (31.2%) |
8945 (18.6%) |
|||
| 80+ | 21,725 (18.6%) |
8591 (40.0%) |
13,134 (13.8%) |
12,200 (21.9%) |
4284 (49.1%) |
7916 (16.9%) |
9525 (15.6%) |
4307 (33.7%) |
5218 (10.8%) |
|||
| Presence of coexisting diseases | ||||||||||||
| Yes | 75,792 (65.0%) |
17,852 (83.1%) |
57,940 (61.0%) |
<0.0001 | 34,448 (61.9%) |
7220 (82.8%) |
27,228 (58.0%) |
<0.0001 | 41,344 (67.9%) |
10,632 (83.3%) |
30,712 (63.8%) |
<0.0001 |
| Presence of at least one cardiovascular disease (I00-I99) | ||||||||||||
| Yes | 26,541 (22.8%) |
7747 (36.0%) |
18,794 (19.8%) |
<0.0001 | 11,888 (21.4%) |
3244 (37.2%) |
8644 (18.4%) |
<0.0001 | 14,653 (24.1%) |
4503 (35.3%) |
10,150 (21.1%) |
<0.001 |
| Presence of at least one endocrine, nutritional and metabolic disease (E00-99) | ||||||||||||
| Yes | 10,165 (8.7%) |
2115 (9.8%) |
8050 (8.5%) |
<0.001 | 5105 (9.2%) |
985 (11.3%) |
4120 (8.8%) |
<0.001 | 5060 (8.3%) |
1130 (8.8%) |
3930 (8.2%) |
0.01 |
| Presence of at least one disease of the genitourinary system (N00-99) | ||||||||||||
| Yes | 6280 (5.4%) |
1808 (8.4%) |
4472 (4.7%) |
<0.001 | 2716 (4.9%) |
718 (8.2%) |
1998 (4.3%) |
<0.001 | 3564 (5.9%) |
1090 (8.5%) |
2474 (5.1%) |
<0.001 |
| COPD | ||||||||||||
| Yes | 1324 (1.1%) |
353 (1.6%) |
971 (1.0%) |
<0.001 | 383 (0.7%) |
81 (0.9%) |
302 (0.6%) |
0.003 | 941 (1.5%) |
272 (2.1%) |
669 (1.4%) |
<0.001 |
| Arterial hypertension | ||||||||||||
| Yes | 12,227 (10.5%) |
1993 (9.3%) |
10,234 (10.8%) |
<0.001 | 5754 (10.3%) |
839 (9.6%) |
4915 (10.5%) |
0.02 | 6473 (10.6%) |
1154 (9.0%) |
5319 (11.0%) |
<0.001 |
| Diabetes mellitus | ||||||||||||
| Yes | 6924 (5.9%) |
1684 (7.8%) |
5240 (5.5%) |
<0.001 | 3140 (5.6%) |
752 (8.6%) |
2388 (5.1%) |
<0.001 | 3874 (6.4%) |
932 (7.3%) |
2852 (5.9%) |
<0.001 |
p—fatal vs. non-fatal COVID-19 cases.